Endocrinology, Vol 137, 2232-2237, Copyright © 1996 by Endocrine Society

ARTICLES

Glucocorticoids inhibit keratinocyte growth factor production in primary dermal fibroblasts

M Chedid, JR Hoyle, KG Csaky and JS Rubin
Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892 USA. chedidm@dc37a.nci.nih.gov

The participation of growth factors in wound healing and tissue repair has been well established. Previous studies demonstrated that the expression of keratinocyte growth factor (KGF) was greatly elevated shortly after injury and that topical application of KGF accelerated healing. Steroidal antiinflammatory agents, specifically glucocorticoids, markedly impair wound healing. The participation of KGF in wound healing led us to examine the effect of glucocorticoids on KGF production. The addition of dexamethasone significantly reduced the level of constitutively produced KGF messenger RNA, protein, and bioactivity in conditioned medium from dermal fibroblasts. This inhibitory effect was observed with a variety of glucocorticoids, whereas nonsteroidal antiinflammatory compounds had little effect on KGF synthesis. The mechanisms by which dexamethasone decreased KGF production include a combination of a diminished transcriptional rate and destabilization of the KGF messenger RNA. Cytokines such as interleukin-1 alpha, platelet-derived growth factor-BB, and transforming growth factor-alpha, typically up-regulated during wound healing, augment KGF expression by dermal fibroblasts. We determined that dexamethasone also blocked this inductive effect. These results suggest that glucocorticoids could inhibit KGF production in the setting of wound repair, which may contribute to the impairment of healing associated with glucocorticoid use.

This article has been cited by other articles:

				C. Danan, M.-L. Franco, P.-H. Jarreau, G. Dassieu, B. Chailley-Heu, J. Bourbon, and C. Delacourt High Concentrations of Keratinocyte Growth Factor in Airways of Premature Infants Predicted Absence of Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., May 15, 2002; 165(10): 1384 - 1387. [Abstract] [Full Text] [PDF]

				L. B. Ware and M. A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940. [Abstract] [Full Text] [PDF]

				P W Finch and A L Cheng Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease Gut, December 1, 1999; 45(6): 848 - 855. [Abstract] [Full Text] [PDF]

				U. Salli, F.F. Bartol, A.A. Wiley, B.J. Tarleton, and T.D. Braden Keratinocyte Growth Factor Expression by the Bovine Corpus Luteum Biol Reprod, July 1, 1998; 59(1): 77 - 83. [Abstract] [Full Text]

				J. A. Parrott and M. K. Skinner Developmental and Hormonal Regulation of Keratinocyte Growth Factor Expression and Action in the Ovarian Follicle Endocrinology, January 1, 1998; 139(1): 228 - 235. [Abstract] [Full Text] [PDF]

				M. L. Casey and P. C. MacDonald Keratinocyte Growth Factor Expression in the Mesenchymal Cells of Human Amnion J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3319 - 3323. [Abstract] [Full Text] [PDF]